+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Cancer Genetics Inc (CGIX) - Financial and Strategic SWOT Analysis Review

  • ID: 4285055
  • SWOT Analysis
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Cancer Genetics Inc (CGI) is a pharmaceutical company that offers diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic information to healthcare professionals, biopharma companies, and cancer centers. CGI’s clinical services include expand DX, test menu, complete program, and summation report. The company offers a range of pharmacogenomics testing services for clinical oncologists, cancer centers, and research institutions, and for biotech and biopharma customers. It works in research collaboration with cancer centers to develop and validate proprietary tests. CGI is headquartered in Rutherford, New Jersey, the US.

Cancer Genetics Inc Key Recent Developments

Feb 05, 2018: Cancer Genetics Announces Resignation Of Panna Sharma As Chief Executive Officer
Dec 11, 2017: Cancer Genetics Advances Understanding of Immune Response and Measurement in Lymphomas by Combining PD-L1 Expression Analysis With RNA Analysis
Nov 27, 2017: Cancer Genetics Appoints Renowned Biotech Entrepreneur Dr. Thomas F. Widmann to its Board of Directors
Nov 09, 2017: Cancer Genetics Reports Record Third Quarter 2017 Revenue and 134% Increase in Contracted Bookings from Major Biotech and Pharmaceutical Companies
Oct 30, 2017: Cancer Genetics a Leader in Personalized Medicine - Launches AntigenID, Solidifying CGI’s Position as a Precision Oncology Leader in the Fast Growing, Rapidly-Evolving Field of Immuno-Oncology Therapy & Drug Development

This comprehensive SWOT profile of Cancer Genetics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cancer Genetics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Cancer Genetics Inc - Key Information
  • Cancer Genetics Inc - Overview
  • Cancer Genetics Inc - Key Employees
  • Cancer Genetics Inc - Key Employee Biographies
  • Cancer Genetics Inc - Key Operational Heads
  • Cancer Genetics Inc - Major Products and Services
  • Cancer Genetics Inc - History
  • Cancer Genetics Inc - Company Statement
  • Cancer Genetics Inc - Locations And Subsidiaries
  • Cancer Genetics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Cancer Genetics Inc - Business Description
  • Cancer Genetics Inc - Corporate Strategy
  • Cancer Genetics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Cancer Genetics Inc - Strengths
  • Cancer Genetics Inc - Weaknesses
  • Cancer Genetics Inc - Opportunities
  • Cancer Genetics Inc - Threats
  • Cancer Genetics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Cancer Genetics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Cancer Genetics Inc, Key Information
  • Cancer Genetics Inc, Key Ratios
  • Cancer Genetics Inc, Share Data
  • Cancer Genetics Inc, Major Products and Services
  • Cancer Genetics Inc, History
  • Cancer Genetics Inc, Key Employees
  • Cancer Genetics Inc, Key Employee Biographies
  • Cancer Genetics Inc, Key Operational Heads
  • Cancer Genetics Inc, Other Locations
  • Cancer Genetics Inc, Subsidiaries
  • Cancer Genetics Inc, Key Manufacturing facilities
  • Cancer Genetics Inc, Key Competitors
  • Cancer Genetics Inc, SWOT Analysis
  • Cancer Genetics Inc, Ratios based on current share price
  • Cancer Genetics Inc, Annual Ratios
  • Cancer Genetics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Cancer Genetics Inc, Performance Chart
  • Cancer Genetics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3